Apic Bio
Latest round
- Series A
Last raised
- Nov 2018
Total raised
- $30M
Investors
- 3
About Apic Bio
Apic Bio, Inc.Founded in 2017 in Cambridge, US, Apic Bio, Inc. specializes in gene therapy solutions.18 mn.Apic Bio, Inc. develops cutting-edge gene therapies that target rare genetic diseases.Apic Bio, Inc.Apic Bio, Inc. The company aims to expand its reach into European and Asian markets by 2023, targeting partnerships with local biotech firms to facilitate this growth. Furthermore, the company is focusing on launching new therapies within the next two years, enhancing its product offerings to address a broader range of genetic disorders.
Who invested in Apic Bio
3 investors across 1 round
See all investors in Apic Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 8, 2018
Amount
$30M
Investors
Questions about Apic Bio
Who invested in Apic Bio?
Apic Bio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apic Bio raised?
Apic Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Apic Bio last raise money?
Apic Bio's most recent round on record is a Series A, in Nov 2018.
What does Apic Bio do?
Apic Bio is a biotechnology company.
Where is Apic Bio headquartered?
Apic Bio is headquartered in Cambridge, US.
Which VCs invest in companies like Apic Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Apic Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Apic Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.